NorthStar Healthcare Income, Inc.
NHHS
$1.82
$0.819981.99%
Weiss Ratings | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Reward Grade | C | |||
Rating Factors | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Fair | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -3,707.28 | |||
Price History | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 606,538.00% | |||
60-Day Total Return | 91.57% | |||
90-Day Total Return | 105.64% | |||
Year to Date Total Return | 91.57% | |||
1-Year Total Return | 91.57% | |||
2-Year Total Return | 106.81% | |||
3-Year Total Return | 29.07% | |||
5-Year Total Return | -- | |||
52-Week High % Change | 0.00% | |||
52-Week Low % Change | 1,819,814.00% | |||
Price | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $1.82 | |||
52-Week Low Price | $0.00 | |||
52-Week Low Price (Date) | Oct 16, 2024 | |||
52-Week High Price (Date) | Feb 20, 2025 | |||
Valuation | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 337.98M | |||
Enterprise Value | 880.19M | |||
Price/Earnings (TTM) | 10.44 | |||
Earnings Per Share (TTM) | 0.17 | |||
Earnings Per Share Growth | -133.17% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.66 | |||
Price/Book (Q) | 1.41 | |||
Enterprise Value/Revenue (TTM) | 4.33 | |||
Price | $1.82 | |||
Enterprise Value/EBITDA (TTM) | 14.97 | |||
Enterprise Value/EBIT | 39.00 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 185.71M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 929 777 3135 | |||
Address | 16 East 34th Street New York, NY 10016 | |||
Website | www.northstarhealthcarereit.com | |||
Country | United States | |||
Year Founded | 2010 | |||
Profitability | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 11.09% | |||
Profit Margin | 15.93% | |||
Management Effectiveness | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 1.23% | |||
Return on Equity | 13.56% | |||
Income Statement | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 148.77M | |||
Total Revenue (TTM) | 203.39M | |||
Revenue Per Share | $1.10 | |||
Gross Profit (TTM) | 71.47M | |||
EBITDA (TTM) | 58.80M | |||
EBIT (TTM) | 22.57M | |||
Net Income (TTM) | 32.40M | |||
Net Income Avl. to Common (TTM) | 32.40M | |||
Total Revenue Growth (Q YOY) | 0.84% | |||
Earnings Growth (Q YOY) | 1,192.19% | |||
EPS Diluted (TTM) | 0.17 | |||
EPS Diluted Growth (Q YOY) | 1,209.44% | |||
Balance Sheet | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 333.46M | |||
Cash Per Share (Q) | $1.80 | |||
Total Current Assets (Q) | 342.93M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 237.87M | |||
Current Ratio (Q) | 0.488 | |||
Book Value Per Share (Q) | $1.29 | |||
Total Assets (Q) | 1.15B | |||
Total Current Liabilities (Q) | 702.88M | |||
Total Debt (Q) | 877.19M | |||
Total Liabilities (Q) | 914.18M | |||
Total Common Equity (Q) | 239.43M | |||
Cash Flow | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 247.64M | |||
Cash from Financing (TTM) | -28.66M | |||
Net Change in Cash (TTM) | 241.71M | |||
Levered Free Cash Flow (TTM) | 37.35M | |||
Cash from Operations (TTM) | 22.74M | |||